CULLEN TANIGUCHI to Radiation-Protective Agents
This is a "connection" page, showing publications CULLEN TANIGUCHI has written about Radiation-Protective Agents.
Connection Strength
1.244
-
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. Cancer Res. 2019 05 01; 79(9):2327-2338.
Score: 0.627
-
Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated Radiation. Sci Rep. 2019 02 13; 9(1):1949.
Score: 0.617